Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Issue Final Device Post-Market Surveillance Plan In February

This article was originally published in The Gray Sheet

Executive Summary

The device center plans to publish the final version of its national device post-market surveillance strategy and select a third-party group to run its MDEpiNet public-private partnership by the end of February.

Advertisement

Related Content

FDA Convenes Industry, Physicians To Create International Transcatheter Valve Registry Consortium
CDRH Sequestration Impact: Training, Standards And Reg Science
Washington Roundup, February 2013
FDA To Issue UDI Database Draft Guidance In March
FDA Expands Partnerships With Universities As Part Of MDEpiNet Program
FDA Post-Market Plan Gains Support, But Many Details Still Lacking
FDA Unveils Plan To Strengthen Device Post-Market Surveillance
Cornell Maps Clinically Meaningful Ortho Device Attributes
CDRH Seeks To Expand Public-Private Medical Device Epidemiology Network
FDA Seeks Public/Private Partners For Device Epidemiology Network

Topics

Advertisement
UsernamePublicRestriction

Register

MT032664

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel